BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Pyxis Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:28 am Sale | 2023-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,938,851 (Position Closed) | Filing |
| 2023-02-13 6:13 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 2,938,851 8.400% | 1,147,500 (+64.06%) | Filing |
| 2021-12-20 5:23 pm Purchase | 2021-12-10 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 1,791,351 5.500% | 1,791,351 (New Position) | Filing |